Stay updated on DLL3-Expressing Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.

Latest updates to the DLL3-Expressing Advanced Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a related topic tag 'Small cell lung carcinoma' and a link to Genetic and Rare Diseases Information Center resources.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page's revision history shows Revision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded MK-6070-001 (Other Identifier) with MSD as the identifier and introduced new dates (2026-02-24, 2026-02-23, 2026-02, 2028-01-28). Removed the previous MSD ID entry and older dates (2026-02-02, 2027-11-03, 2026-01-29, 2026-01).SummaryDifference0.3%

- Check54 days agoChange DetectedThe page now shows Revision: v3.4.2 replacing Revision: v3.4.1, which appears to be a minor site maintenance update with no impact on the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe study status on the page changed to Active, not recruiting, and several investigator/site contact details were removed.SummaryDifference4%

Stay in the know with updates to DLL3-Expressing Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.